Table 3 Differences in antibiotic susceptibility by Enterobacteriaceae type
Antibiotics susceptibility | Total (N=131) | Escherichia coli (N=10) | Klebsiella pneumoniae (N=90) | Enterobacter spp. (N=13) | Klebsiella oxytoca (N=7) | Citrobacter spp. (N=4) | Serratia marcescens (N=7) | ||
|---|---|---|---|---|---|---|---|---|---|
Susceptible | Intermediate | Resistant | |||||||
Ampicillin | 1 (1) | 0 | 130 (99) | 0 | 1 (1) | 0 | 0 | 0 | 0 |
Ampicillin/sulbactam | 0 | 0 | 131 (100) | 0 | 0 | 0 | 0 | 0 | 0 |
Amikacin | 99 (76) | 2 (2) | 30 (23) | 9 (90) | 66 (73) | 9 (69) | 6 (86) | 4 (100) | 5 (71) |
Aztreonam | 6 (5) | 0 | 125 (95) | 3 (30) | 0 | 0 | 3 (43) | 0 | 0 |
Ceftazidime | 3 (2) | 0 | 128 (98) | 0 | 0 | 0 | 1 (14) | 0 | 2 (29) |
Cefotaxime | 1 (1) | 0 | 130 (99) | 1 (10) | 0 | 0 | 0 | 0 | 0 |
Ciprofloxacin | 18 (14) | 3 (2) | 110 (84) | 1 (10) | 7 (8) | 3 (23) | 4 (57) | 2 (50) | 1 (14) |
Cefuroxime | 0 | 0 | 131 (100) | 0 | 0 | 0 | 0 | 0 | 0 |
Cefazoline | 0 | 0 | 131 (100) | 0 | 0 | 0 | 0 | 0 | 0 |
Cefepime | 8 (6) | 2 (2) | 121 (92) | 0 | 2 (2) | 2 (15) | 3 (43) | 0 | 1 (14) |
Cefoxitin | 1 (1) | 0 | 130 (99) | 0 | 1 (1) | 0 | 0 | 0 | 0 |
Gentamicin | 51 (39) | 12 (9) | 68 (52) | 5 (50) | 29 (32) | 5 (39) | 2 (29) | 3 (75) | 7 (100) |
Levofloxacin | 12 (9) | 4 (3) | 115 (88) | 1 (10) | 3 (3) | 4 (31) | 3 (43) | 0 | 1 (14) |
Tobramycin | 4 (3) | 4 (3) | 123 (94) | 1 (10) | 1 (1) | 2 (15) | 0 | 0 | 0 |
Piperacillin/tazobactam | 1 (1) | 5 (4) | 125 (95) | 0 | 0 | 0 | 0 | 0 | 1 (14) |
TMP/SMX | 30 (23) | 0 | 101 (77) | 2 (20) | 18 (20) | 1 (8) | 2 (29) | 1 (25) | 6 (86) |
Tigecycline | 54 (41) | 9 (7) | 68 (52) | 7 (70) | 37 (41) | 2 (15) | 4 (57) | 2 (50) | 2 (29) |
Tetracycline | 12 (9) | 1 (1) | 118 (90) | 1 (10) | 9 (10) | 1 (8) | 1 (14) | 0 | 0 |
Ticarcillin/clavulanate | 1 (1) | 1 (1) | 129 (99) | 0 | 1 (1) | 0 | 0 | 0 | 0 |
Colistin* | 28/29 (97) | 0/29 | 1/29 (3) | 4/4 (100) | 18/19 (95) | 1/1 (100) | 3/3 (100) | 2/2 (100) | 0/0 |